As­traZeneca pays out $425M to set­tle lit­i­ga­tion over Prilosec and Nex­i­um but ad­mits no wrong­do­ing

As­traZeneca has agreed to pay out $425 mil­lion to set­tle thou­sands of com­bined law­suits filed against the com­pa­ny over acid re­flux med­i­cine Nex­i­um and heart­burn drug Prilosec, the com­pa­ny said Tues­day.

The agree­ments “ef­fec­tive­ly re­solve” the cas­es that were pend­ing in sev­er­al courts: the US Dis­trict Court for the Dis­trict of New Jer­sey, the Delaware Su­pe­ri­or Court and the New Jer­sey Su­pe­ri­or Court. The law­suits al­leged that As­traZeneca did not do enough to warn pa­tients and doc­tors about the risk of con­tract­ing chron­ic kid­ney dis­ease and oth­er re­lat­ed is­sues from long-term use of the pre­scrip­tion-on­ly med­i­cines, and that the com­pa­nies con­cealed the risks of the med­ica­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER